After a volatile decade in which approvals swung sharply from year to year, 2025’s total pushed past long-term norms, exceeding the 10-year average
The company expects meaningful revenue contribution from this long-term agreement
This Yearbook aims to distinguish those companies that have demonstrated strengths in corporate sustainability
International Meeting of World Pharmacopoeias serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
He advocated for a "PPP + PPP" collaboration, urging the public and private sectors within India to partner with their counterparts in other countries
The company has reported total income of Rs.77.0791 crores during the period ended December 31, 2022 as compared to Rs.69.9191 crores during the period ended December 31, 2021.
In fact, the overall CPHI Pharma Index – a collateralised metric of all major ranking categories – has risen by more than 8%, the largest year-on-year gain in the survey’s six year history
Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
